Long-acting oxytetracycline composition
AssigneeNorbrook Laboratories Limited
InventorsAlan Patterson, Drew Holmes
Life of this patent
Estimating the term…
Loading patent…
AssigneeNorbrook Laboratories Limited
InventorsAlan Patterson, Drew Holmes
Estimating the term…
An injectable composition is described having a higher residual effect with reduced detrimental effects such as pain at injection site, swelling, tissue irritancy or necrosis. The composition contains as active principle a tetracycline compound, either as the free base or a salt thereof with a physiologically acceptable acid, complexed with a substantially equimolar amount of a magnesium compound, and is solubilized in a water miscible solvent system comprising glycerol formal in a an amount of about 40 (v/v); with from about 1% to about 20% (v/v) polyethylene glycol and optionally containing a pH modifier in an amount sufficient to maintain a physiologically acceptable pH. In addition, the composition may further comprise a thickener, such as polyvinyl in an amount of about 10% (w/v). The balance of the composition comprises water.
A composition containing as active principle an amount of a tetracycline compound effective for antibiotic activity, either as the free base or a salt thereof with a physiologically acceptable acid, complexed with a substantially equimolar amount of a magnesium compound, solubilized in a water miscible solvent system comprising,
A composition containing contains about 30% (w/v) oxytetracycline as active principle, complexed with a substantially equimolar amount of a magnesium compound, solubilized in a water miscible solvent system comprising glycerol formal in an amount of about 40 (v/v) with from about 1% to about 15% (v/v) polyethylene glycol 1500, said composition optionally containing a pH modifier in an amount sufficient to maintain a physiologically acceptable pH, the balance being made up with water q.s.
Dependencies are inferred from the claim text.